Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial
- Submitting institution
-
University of Newcastle upon Tyne
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 260703-64397-1266
- Type
- D - Journal article
- DOI
-
10.1016/S2352-3018(19)30195-X
- Title of journal
- The Lancet HIV
- Article number
- -
- First page
- 655
- Volume
- 6
- Issue
- 10
- ISSN
- 2405-4704
- Open access status
- Not compliant
- Month of publication
- October
- Year of publication
- 2019
- URL
-
https://doi.org/10.1016/S2352-3018(19)30195-X
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
11
- Research group(s)
-
D - Immunity and Inflammation
- Citation count
- 8
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
